MichaelJ.NaslundMD

Urology • Baltimore, MD

Trauma & Reconstructive Surgery

Professor of Urology, University MD School of Medicine

Join to view full profile

Dr. Naslund is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Naslund's full profile

Already have an account?

Office
22 S Greene St
Baltimore, MD 21201
Phone+1 410-328-5300

Fax+1 410-328-2109

Education & Training

Johns Hopkins UniversityResidency, Urology, 1983 - 1987
Johns Hopkins UniversityResidency, Surgery, 1981 - 1983
Johns Hopkins University School of MedicineClass of 1981

Certifications & Licensure

MD State Medical License 1981 - 2025
FL State Medical License 2019 - 2021
American Board of Urology Urology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRS Start of enrollment: 2015 Apr 01
Withdrawn
Focal Therapy for Prostate Cancer Start of enrollment: 2013 Feb 01
Withdrawn
Phase 2

Publications & Presentations

PubMed

4 citations
Prostate cancer grade downgrading at time of prostatectomy provides risk-stratification insight into future tumor behavior after prostatectomy.
Shu Wang, Shu Wang, J Ryan Russell, Max Drescher, Ashley Park
The Prostate. 2022-12-01
19 citations
PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer.
James W Frisbie, Alexa J Van Besien, Adrianna Lee, Linhan Xu, Shu Wang
Prostate Cancer and Prostatic Diseases. 2023-06-01
19 citations
Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of Phytotherapy for Benign Prostatic Hyperplasia
Jeannette Y. Lee, Gerald L. Andriole, Andrew L. Avins, E. David Crawford, Harris E. Foster
Clinical Trials. 2009-12-09

Press Mentions

What Men Need to Know About Testicular CancerJune 24th, 2021

Grant Support

Alternative Therapies For Benign Prostatic SymptomsNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2010